Therma Bright Inc V.THRM

THRM

[Smokey1958]

From the recent interview with Rob the following:

Benepod e-commerce site
Venowave e-commerce site coming soon
DME Authority ramping up sales for Venowave

Great updates but not why most are invested here.

Cross Reactivity study coming to a conclusion ....based on recent manufacturing agreements the final stages of this study will meet all expectations.

POC study clearly underway if Rob is hoping to have the final submissions for both studies in before Christmas.

If he also hopes the FDA can review these (a week to render a decision?) before Christmas he must believe these submissions will be forwarded to the FDA no later than the end of next week.

In the meantime the director of the covid science advisory table for Ontario is questioning the under supply of rapid antigen tests.

AcuVid could soon become a  viable alternative to currently under utilized tests.

GLTE!!!

[nrv090909]

Once Acuvid is FDA EUA approved, I would think airports and cruises would be the major contracts in terms of domestic sales. For international, the demand is going to sky rocket (India, South America, Africa, middle east and Europe. I personally think it will be $8/share on FDA approval, then $19 per share on domestic contracts and $85/share on international contracts. With Venowave and Benepod

[jpm59]

jeepers creepers NRV, that means @ $130 per share  THRM would only be worth $26 Billion + dollars,,,,time to see a doctor,,,lol

[nrv090909]

it is a rough estimate. If we get FDA approval, easily $4/share. Start pre booking your Range Rover's. 

[dmshediac]

This post has been removed in accordance with Community Policy

[hk1966]

I'm lovin it to borrow an expression. I will retire if that comes to pass....lol